Ted Jenkins | Vice President-Investor Relations |
Ankit Mahadevia | Chief Executive Officer |
David Melnick | Chief Medical Officer |
Sath Shukla | Chief Financial Officer |
Louise Chen | Cantor |
Ram Selvaraju | H.C. Wainwright |
Kevin DeGeeter | Oppenheimer |
Elaine Kim | Berenberg |
Good afternoon, and welcome to the Spero Therapeutics First Quarter of 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following the company’s formal remarks, we will open up the call for questions. Please be advised that this call is being recorded and a replay will be available.
You can find information on the replay and further information related to today's announcement on the Spero Therapeutics website at www.sperotherapeutics.com.